Smith Cynthia (CIK 1609480) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-25). Recent activity: Buy SPRO (10,000 shares), Buy AGIO (2,816 shares), Buy AKBA (35,700 shares), Buy AGIO (2,302 shares), Buy AGIO (2,120 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Spero Therapeutics, Inc. (SPRO) | Director | Buy | 10,000 | $0 |
| 2026-06-23 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 2,816 | $0 |
| 2026-06-22 | Akebia Therapeutics, Inc. (AKBA) | Director | Buy | 35,700 | $0 |
| 2025-08-13 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 2,302 | $0 |
| 2025-06-23 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 2,120 | $0 |
| 2025-06-16 | Spero Therapeutics, Inc. (SPRO) | Director | Buy | 20,000 | $0 |
| 2025-06-11 | Akebia Therapeutics, Inc. (AKBA) | Director | Buy | 35,700 | $0 |
Source: SEC Form 4 filings · as of 2026-06-25